Health policy and outcome research

Citations 1-9 of 9 total displayed.

Most recent content (1 Aug 2009):

Original Articles
Cost-Effectiveness of Radiofrequency Catheter Ablation Compared With Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation

Matthew R. Reynolds, Peter Zimetbaum, Mark E. Josephson, Ethan Ellis, Tatyana Danilov, and David J. Cohen
Circ Arrhythm Electrophysiol 2009;2:362-369; published online before print as doi:10.1161/CIRCEP.108.837294 [Abstract] [Full text]  

Past content (since Oct 2008):

Original Article
Treatment of Atrial Fibrillation with Anti–arrhythmic Drugs or Radio Frequency Ablation: Two Systematic Literature Reviews and Meta–analyses

Hugh Calkins, Matthew R. Reynolds, Peter Spector, Manu Sondhi, Yingxin Xu, Amber Martin, Catherine J. Williams, and Isabella Sledge
Circ Arrhythm Electrophysiol published June 2, 2009, doi:10.1161/CIRCEP.108.824789 [Abstract]  

Editorials
Atrial Fibrillation Through the Patient’s Eyes

Edward P. Havranek
Circ Arrhythm Electrophysiol 2009;2:213-214, doi:10.1161/CIRCEP.109.876904 [Full text]  

Original Article
Cost-Effectiveness of Radiofrequency Catheter Ablation Compared with Antiarrhythmic Drug Therapy for Paroxysmal Atrial Fibrillation

Matthew R. Reynolds, Peter Zimetbaum, Mark E. Josephson, Ethan Ellis, Tatyana Danilov, and David J. Cohen
Circ Arrhythm Electrophysiol published April 17, 2009, doi:10.1161/CIRCEP.108.837294 [Abstract]  

Original Articles
Risk Factors for Mortality in Patients With Cardiac Device-Related Infection

Timir S. Baman, Sanjaya K. Gupta, Javier A. Valle, and Elina Yamada
Circ Arrhythm Electrophysiol 2009;2:129-134; published online before print as doi:10.1161/CIRCEP.108.816868 [Abstract] [Full text]  

Original Article
Risk Factors for Mortality in Patients with Cardiac Device-Related Infection

Timir S. Baman, Sanjaya K. Gupta, Javier A. Valle, and Elina Yamada
Circ Arrhythm Electrophysiol published February 13, 2009, doi:10.1161/CIRCEP.108.816868 [Abstract]  

Editorials
Publicly Reporting Implantable Cardioverter Defibrillator Outcomes: Grading the Report Card

Stephen C. Hammill and Jeptha Curtis
Circ Arrhythm Electrophysiol 2008;1:235-237, doi:10.1161/CIRCEP.108.819300 [Full text]  

Original Articles
Patient and Implanting Physician Factors Associated With Mortality and Complications After Implantable Cardioverter-Defibrillator Implantation, 2002–2005

Sana M. Al-Khatib, Melissa A. Greiner, Eric D. Peterson, Adrian F. Hernandez, Kevin A. Schulman, and Lesley H. Curtis
Circ Arrhythm Electrophysiol 2008;1:240-249, doi:10.1161/CIRCEP.108.777888 [Abstract] [Full text]  

Controversies in Arrhythmia and Electrophysiology
Should patients with congenital heart disease and a systemic ventricular ejection fraction less than 30% undergo prophylactic implantation of an ICD?: Implantable Cardioverter Defibrillator Implantation Guidelines Based Solely on Left Ventricular Ejection Fraction Do Not Apply to Adults With Congenital Heart Disease

John K. Triedman
Circ Arrhythm Electrophysiol 2008;1:307-316, doi:10.1161/CIRCEP.108.805903 [Full text]